DeutschNewstral
Article
bizjournals.com on 2015-03-30 16:42
Shares of Raleigh's BioDelivery plummet 30 percent
Related news
- Raleigh's BioDelivery shelves $150 million in sharesbizjournals.com
- Here's how Raleigh's BioDelivery plans to spend $50 millionbizjournals.com
- How Raleigh's BioDelivery will use $10M it got from partner on pain drugbizjournals.com
- Raleigh's BioDelivery hires former Salix sales workersbizjournals.com
- With FDA approval, Raleigh's BioDelivery sees 10% stock bouncebizjournals.com
- Xylem CEO: Raleigh's Sensus grew 7 percentbizjournals.com
- FDA ruling on pain drug developed by Raleigh's BioDelivery expected Fridaybizjournals.com
Raleigh's wasteland; Durham's shitstorm of condo-plexesindyweek.com- Zillow shares plummet 66 percent after stock splitbizjournals.com
- Raleigh's top 10 restaurants of October, according to OpenTable (Slideshow)bizjournals.com
- Image of the day: A walk beneath Raleigh's Edison Apartmentsbizjournals.com
- Image of the day: Wiring Raleigh's Lincoln Apartmentsbizjournals.com
- Former CEO of Raleigh's PrecisionHawk has a new startupbizjournals.com
Hidden in plain sight: Remnants of Raleigh's historic streetcar systemWRAL- Raleigh's soaring cost of living puts more pressure on businessesbizjournals.com
- Brookings: Raleigh's one of 'hottest' metros for advanced industriesbizjournals.com
- Raleigh's one of top 15 U.S. cities for recession reboundbizjournals.com
- Raleigh's one of top 20 cities for singlesbizjournals.com
- Image of the day: North Hills tower reflects Raleigh's futurebizjournals.com
- Mayor Baldwin: Have study group assess future of Raleigh's arenabizjournals.com